Projects per year
Overview
Profile summary
Education and qualifications
- 2005 PhD dissertation, Uppsala University, Sweden, Orexin Receptors in Recombinant CHO Cells. Signaling to Short- and Long Term Cells responses
- 2004 Transfer, Uppsala University, Sweden
- 1997 Degree of Master of Science, Uppsala University, Sweden Immunomodulatory-and-cytokine gene-cancer therapy
- 1996 BScs, Uppsala University, Sweden
Professional memberships
Member of South of England Brain Tumour Alliance (SEBTA)
Supervised research degrees
Supervisor of Ph.D. students: 6 students (DoS), 4 students (co-supervisor)
Teaching interests
Teaching experience
I enjoy sharing my knowledge and always appreciate teaching in which I have over 20 years of experience.
Uppsala University, Sweden
From 1998 to 2005 I taught medical-, pharmacology- and nurse-students in the following subjects: hemodynamics (blood-vascular circulation-system), the safety of medical equipment (current), optical refraction of the eye, heart anatomy (dissection), oscilloscope and pacemaker and muscle structure and function. During this time I also supervised undergraduate and BSc biomedical students and lab assistants.
Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK
From 2006 until present I have supervised PhD, MSc, BSc, and undergraduate students in different projects. Between 2006 and 2007 I taught medical students in 'Neurodegenerativedisorders' and 'Disease prevention and management-vaccines ‘and 2019 biomedical students in 'Tumours of the nervous system'.
Teaching education
- 2014 Internal and External Doctoral Examiners training
- 2011 Learning and Teaching for general Teaching Associates (GTA) training including: Theories of Learning and Teaching, Planning Sessions and Delivering Presentations, Learning in Groups, Evaluating Teaching and Giving Feedback, Assessment, Dealing with difficult Situations and Assessment Criteria and Marketing.
- 2008 Problem-based learning (PBL) facilitator training.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 3 Active
-
RETREAT: Phase 0 (early-phase) clinical trial repurposing anti-retroviral drugs to treat NF2 related tumours RETREAT.
Ammoun, S. (PI - Principal Investigator) & Hanemann, O. (PI - Principal Investigator)
23/08/24 → …
Project: Research
-
Investigation of the role of cellular prion protein (PrPC) in the development of meningioma.
Ammoun, S. (PI - Principal Investigator)
1/04/18 → …
Project: Research
-
Investigation of the role of cellular prion protein (PrPC) in meningioma and schwannoma drug resistance
Ammoun, S. (PI - Principal Investigator)
1/09/22 → …
Project: Research
Research output
-
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours
Dave, F., Herrera Keane, K., Lockley, A., van de Weijer, L. L., Henderson, S., Sofela, A., Hook, L., Ercolano, E., Adams, C., Hilton, D. A., Atangana Maze, E., Kurian, K. M., Ammoun, S. & Hanemann, O., 23 Aug 2024, In: Oncogene. 43, 41, p. 3049-3061 13 p.Research output: Contribution to journal › Article › peer-review
-
Human Endogenous Retrovirus Type K promotes proliferation of Merlin-negative schwannoma and meningioma which can be inhibited by anti-retroviral and anti-TEAD drugs
Hanemann, C., Maze, E., Agit, B., Reeves, S., Hilton, D., Parkinson, D., Laraba, L., Ercolano, E., Kurian, K., Belshaw, R. & Ammoun, S., 2022.Research output: Contribution to conference › Conference paper (not formally published) › peer-review
File11 Downloads (Pure) -
Abstract 1164: Human endogenous retrovirus type K promotes proliferation of Merlin negative schwannoma and meningioma which can be inhibited by anti-retroviral and anti-TEAD drugs
Ammoun, S., Maze, E., Agit, B., Belshaw, R. & Hanemann, C., 1 Jul 2021.Research output: Contribution to conference › Conference paper (not formally published) › peer-review
-
Abstract 941: TAM receptors as potential therapeutic targets in NF2-related schwannomas and meningiomas
Dave, F., Ammoun, S. & Hanemann, C., 1 Jul 2021.Research output: Contribution to conference › Conference paper (not formally published) › peer-review
-
Fibulin-2: A novel biomarker for differentiating grade ii from grade i meningiomas
Sofela, A. A., Hilton, D. A., Ammoun, S., Baiz, D., Adams, C. L., Ercolano, E., Jenkinson, M. D., Kurian, K. M., Teo, M., Whitfield, P. C., Sahm, F. & Hanemann, C. O., 8 Jan 2021, In: International Journal of Molecular Sciences. 22, 2, p. 1-13 13 p., 560.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure)
Activities
- 2 Supervision
-
The role of prion protein in the development of merlin-negative meningiomas
Ammoun, S. (Examiner)
2021Activity: Examination and supervision › Supervision › Internal
-
Targeting MERTK receptor in Merlin-negative meningioma and schwannoma tumour cells and tumour-associated macrophages
Ammoun, S. (Examiner)
2024Activity: Examination and supervision › Supervision › Internal